-
1341
Stem cells in gastroenterology: prospects and problems
Published 2011-12-01“…In therapeutic aspect of gastrointestinal and liver diseases inflammatory bowel diseases, colorectal cancer and decompensated liver cirrhosis seem to be most perspective at the present stage. …”
Get full text
Article -
1342
Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
Published 2010-02-01“…Decrease of severity of fibrosis (for prophylaxis of liver cirrhosis and hepatocellular carcinoma development) is one of the basic criteria of efficacy of treatment of chronic liver diseases. Now various strategies of influence on fibrosis are discussed, including elimination of etiological factor, suppression of inflammation and specific antifibrotic therapy.Conclusion. …”
Get full text
Article -
1343
-
1344
Critical evaluation of pathogenic factors of primary biliary cirrhosis
Published 2013-07-01“…Primary biliary cirrhosis (PBC) is related to the group of autoimmune cholestasisassociated liver diseases. In the last years prevalence of PBC increased considerably, especially – in Northern European countries. …”
Get full text
Article -
1345
Radiological diagnostic methods in gastroenterology
Published 2018-08-01“…Radiological signs at chronic diffuse liver diseases, disorders of portal blood flow and associated extrahepatic hemodynamic disorders are present. …”
Get full text
Article -
1346
Veillonella Bacteremia in Alcoholic Hepatitis
Published 2021-01-01“…Veillonella species have been correlated with disease severity and hepatic encephalopathy in liver diseases such as autoimmune hepatitis and cirrhosis. …”
Get full text
Article -
1347
-
1348
Endometrioma of the Liver: A Case Report and Review of the Literature
Published 2019-01-01Get full text
Article -
1349
Feature Selection Method Based on Artificial Bee Colony Algorithm and Support Vector Machines for Medical Datasets Classification
Published 2013-01-01“…The developed approach conventionally used in liver diseases and diabetes diagnostics, which are commonly observed and reduce the quality of life, is developed. …”
Get full text
Article -
1350
-
1351
PLIN5 contributes to lipophagy of hepatic stellate cells induced by inorganic arsenic
Published 2025-01-01“…This research offers a novel perspective on the mechanisms of arsenic-induced HSCs activation and liver lipid metabolism, potentially guiding new strategies for the prevention and treatment of arsenic-related liver diseases.…”
Get full text
Article -
1352
A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion
Published 2025-03-01“…Hepatitis B virus (HBV) represents one of the major pathogenic factor that leads to chronic liver diseases and the development of hepatocellular carcinoma (HCC). …”
Get full text
Article -
1353
13C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
Published 2017-01-01“…Assessment of the liver function, and the need of constant monitoring of the organ’s capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. …”
Get full text
Article -
1354
Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis
Published 2011-12-01“…Obtained data assume, that infiltration of the liver by leukocytes, in particular neutrophiles, in combination to ascending necrotic destruction of peripheral cells of innate and adaptive immunity can be the essential pathogenic mechanism at inflammatory liver diseases of T-cell origin.…”
Get full text
Article -
1355
Mesona chinensis Benth polysaccharides alleviates liver injury by beneficial regulation of gut microbiota in cyclophosphamide-induced mice
Published 2022-01-01“…In short, the prevention of CTX-induced liver injury by supplementing MP is achieved at least in part by regulating the community structure of the gut microbiota, and MP is expected to be a potential prebiotic to treat and prevent liver diseases.…”
Get full text
Article -
1356
Genetic Cholestasis: Lessons from the Molecular Physiology of Bile Formation
Published 2000-01-01“…Progressive familial intrahepatic cholestasis (PFIC) is a group of severe genetic cholestatic liver diseases of early life. PFIC types 1 and 2 are characterized by cholestasis and a low to normal serum gamma-glutamyltransferase (GGT) activity, whereas in PFIC type 3, the serum GGT activity is elevated. …”
Get full text
Article -
1357
Silver carp muscle hydrolysate ameliorated atherosclerosis and liver injury in apoE-/- mice: the modulator effects on enterohepatic cholesterol metabolism
Published 2024-11-01“…Our findings provided new knowledge for the application of SCH in ameliorating CVDs and liver diseases.…”
Get full text
Article -
1358
Histomorphologic liver abnormalities in a group of alcoholic patients
Published 2010-11-01“…<strong>Background</strong>: the ingestion of alcohol has been directly involved in the development of liver diseases. Nowadays, the liver damage by ethanol is a serious health problem all over the world. …”
Get full text
Article -
1359
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
Published 2025-01-01“…The study highlights the interplay between α-amanitin, NLRP3, and PPAR-γ in hepatotoxicity, proposing potential therapeutic targets for mushroom poisoning-induced liver diseases.…”
Get full text
Article -
1360